Range and Heterogeneity of Outcomes in Randomized Trials of Pediatric Chronic Kidney Disease

Journal of Pediatrics

Volumn 186, Issue , 2017, Pages 110-117.e11

  Chong, Lauren S H ^a,b   Sautenet, Benedicte ^a,b,c,d,e   Tong, Allison ^a,b   Hanson, Camilla S ^a,b   Samuel, Susan ^f   Zappitelli, Michael ^g   Dart, Allison ^h   Furth, Susan ⁱ   Eddy, Allison A ^j   Groothoff, Jaap ^k   Webb, Nicholas J A ^l   Yap, Hui Kim ^m   Bockenhauer, Detlef ⁿ   Sinha, Aditi ^o   Alexander, Stephen I ^b   Goldstein, Stuart L ^p   Gipson, Debbie S ^q   Raman, Gayathri ^a   Craig, Jonathan C ^a,b  

^a UNIVERSITY OF SYDNEY   (Australia)

^b CHILDREN S HOSPITAL AT WESTMEAD   (Australia)

^c UNIVERSITÉ DE TOURS   (France)

^d Tours Hospital   (France)

^e PARIS DESCARTES UNIVERSITY   (France)

^f UNIVERSITY OF CALGARY   (Canada)

^g MONTREAL CHILDREN S HOSPITAL   (Canada)

^h UNIVERSITY OF MANITOBA   (Canada)

ⁱ CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

^j BC CHILDREN S HOSPITAL   (Canada)

^k EMMA CHILDREN S HOSPITAL   (Netherlands)

^l UNIVERSITY OF MANCHESTER   (United Kingdom)

^m NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

ⁿ UNIVERSITY COLLEGE LONDON   (United Kingdom)

^o ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

^p CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

^q UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

more..

Author keywords

children; chronic kidney disease; outcomes; systematic review

Indexed keywords

ALBUMIN; LIPID; PROTEIN;

ALBUMINURIA; ARTICLE; BLOOD PRESSURE; BODY HEIGHT; BODY MASS; BODY WEIGHT; CARDIOVASCULAR DISEASE; CHILD; CHRONIC KIDNEY FAILURE; CLINICAL OUTCOME; COCHRANE LIBRARY; HEMODIALYSIS; HUMAN; INFECTION; KIDNEY FUNCTION; KIDNEY TRANSPLANTATION; MORTALITY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEINURIA; PUBERTY; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL (TOPIC); REGISTER; RELAPSE; REMISSION; SKIN DISEASE; ADOLESCENT; AGE; INFANT; KIDNEY FUNCTION TEST; NEWBORN; PRESCHOOL CHILD; RECURRENT DISEASE; RENAL INSUFFICIENCY, CHRONIC; YOUNG ADULT;

ADOLESCENT; AGE FACTORS; BLOOD PRESSURE; CHILD; CHILD, PRESCHOOL; HUMANS; INFANT; INFANT, NEWBORN; KIDNEY FUNCTION TESTS; OUTCOME ASSESSMENT (HEALTH CARE); QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RECURRENCE; RENAL INSUFFICIENCY, CHRONIC; YOUNG ADULT;

EID: 85018807869     PISSN: 00223476     EISSN: 10976833     Source Type: Journal    
DOI: 10.1016/j.jpeds.2017.03.034     Document Type: Article

References (71)

1. Shirkey, H., Therapeutic orphans. J Pediatr 72 (1968), 119–120.
2. Cohen, E., Uleryk, E., Jasuja, M., Parkin, P.C., An absence of pediatric randomized controlled trials in general medical journals, 1985-2004. J Clin Epidemiol 60 (2007), 118–123.
3. Joseph, P.D., Craig, J.C., Caldwell, P.H.Y., Clinical trials in children. Br J Clin Pharmacol 79 (2015), 357–369.
4. Smyth, R.L., Making a difference: the clinical research programme for children. Arch Dis Child 92 (2007), 835–837.
5. National Institutes of Health, NIH policy and guidelines on the inclusion of children as participants in research involving human subjects. https://grants.nih.gov/grants/guide/notice-files/not98-024.html, 1998 Accessed September 30, 2016.
6. International Pediatric Association, IPA statement on equity and quality healthcare for children of the world. http://ipa-world.org/uploadedbyfck/WSO_0001.pdf, 2006 Accessed September 30, 2016.
7. World Health Organisation, Medicines for children: resources, progress reports and scientific publications: medicines: medicines for children. Fact sheet N°34, 1 June http://www.who.int/childmedicines/publications/en/, 2010 Accessed September 30, 2016.
8. Bellanti, F., Della Pasqua, O., Modelling and simulation as research tools in paediatric drug development. Eur J Clin Pharmacol 67:suppl 1 (2011), 75–86.
9. Schreiner, M.S., Paediatric clinical trials: redressing the imbalance. Nat Rev Drug Discov 2 (2003), 949–961.
10. Wilson, J.T., An update on the therapeutic orphan. Pediatrics 104 (1999), 585–590.
11. Klassen, T.P., Hartling, L., Hamm, M., van der Lee, J.H., Ursum, J., Offringa, M., StaR Child Health: an initiative for RCTs in children. Lancet 374 (2009), 1310–1312.
12. Sammons, H.M., Gray, C., Hudson, H., Cherrill, J., Choonara, I., Safety in paediatric clinical trials—a 7-year review. Acta Paediatr 97 (2008), 474–477.
13. Benjamin, D., Clinical Trials Approach and the Pediatric Trials Network. American Society for Clinical Pharmacology and Therapeutics (ASCPT) Conference, March 12-17, 2012.
14. Ruperto, N., Martini, A., Networking in paediatrics: the example of the Paediatric Rheumatology International Trials Organisation (PRINTO). Arch Dis Child 96 (2011), 596–601.
15. Al-Shahi Salman, R., Beller, E., Kagan, J., Hemminki, E., Phillips, R.S., Savulescu, J., et al. Increasing value and reducing waste in biomedical research regulation and management. Lancet 383 (2014), 176–185.
16. Chalmers, I., Bracken, M.B., Djulbegovic, B., Garattini, S., Grant, J., Gulmezoglu, A.M., et al. How to increase value and reduce waste when research priorities are set. Lancet 383 (2014), 156–165.
17. Chalmers, I., Glasziou, P., Avoidable waste in the production and reporting of research evidence. Lancet 374 (2009), 86–89.
18. Chan, A.W., Song, F., Vickers, A., Jefferson, T., Dickersin, K., Gotzsche, P.C., et al. Increasing value and reducing waste: addressing inaccessible research. Lancet 383 (2014), 257–266.
19. Ioannidis, J.P., Greenland, S., Hlatky, M.A., Khoury, M.J., Macleod, M.R., Moher, D., et al. Increasing value and reducing waste in research design, conduct, and analysis. Lancet 383 (2014), 166–175.
20. Macleod, M.R., Michie, S., Roberts, I., Dirnagl, U., Chalmers, I., Ioannidis, J.P.A., et al. Biomedical research: increasing value, reducing waste. Lancet 383 (2014), 101–104.
21. Isaac, A., Saginur, M., Hartling, L., Robinson, J.L., Quality of reporting and evidence in American Academy of Pediatrics guidelines. Pediatrics 131 (2013), 732–738.
22. Tugwell, P., Boers, M., Brooks, P., Simon, L., Strand, V., Idzerda, L., OMERACT: an international initiative to improve outcome measurement in rheumatology. Trials 8 (2007), 1–6.
23. Sinha, I., Jones, L., Smyth, R.L., Williamson, P.R., A systematic review of studies that aim to determine which outcomes to measure in clinical trials in children. PLoS Med, 5, 2008 e96.
24. DeMauro, S.B., Giaccone, A., Kirpalani, H., Schmidt, B., Quality of reporting of neonatal and infant trials in high-impact journals. Pediatrics 128 (2011), e639–44.
25. Anttila, H., Malmivaara, A., Kunz, R., Autti-Ramo, I., Makela, M., Quality of reporting of randomized, controlled trials in cerebral palsy. Pediatrics 117 (2006), 2222–2230.
26. Johnston, B.C., Shamseer, L., da Costa, B.R., Tsuyuki, R.T., Vohra, S., Measurement issues in trials of pediatric acute diarrheal diseases: a systematic review. Pediatrics 126 (2010), e222–31.
27. Rubin, T., Clayton, J., Adams, D., Jou, H., Vohra, S., Systematic review of outcome measures in trials of pediatric anaphylaxis treatment. BMC Pediatr, 14, 2014, 158.
28. European Medicines Agency, Paediatric medicines: overview. http://www.ema.europa.eu/ema/index.jsp?curl=pages/regulation/general/general_content_000023.jsp, 2016 Accessed September 30, 2016.
29. National Institutes of Health, Best Pharmaceuticals for Children Act (BPCA) activities at the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD). https://bpca.nichd.nih.gov/Pages/default.aspx, 2016 Accessed September 30, 2016.
30. Johnston, B.C., Shamseer, L., Costa, B.R., Tsuyuki, R.T., Vohra, S., Measurement issues in trials of pediatric acute diarrheal diseases: a systematic review. Pediatrics 126 (2010), e222–31.
31. McDonald, S.P., Craig, J.C., Long-term survival of children with end-stage renal disease. N Engl J Med 350 (2004), 2654–2662.
32. Carey, W.A., Martz, K.L., Warady, B.A., Outcome of patients initiating chronic peritoneal dialysis during the first year of life. Pediatrics 136 (2015), e615–22.
33. Davis, I.D., Greenbaum, L.A., Gipson, D., Wu, L.L., Sinha, R., Matsuda-Abedini, M., et al. Prevalence of sleep disturbances in children and adolescents with chronic kidney disease. Pediatr Nephrol 27 (2012), 451–459.
34. Gerson, A.C., Wentz, A., Abraham, A.G., Mendley, S.R., Hooper, S.R., Butler, R.W., et al. Health-related quality of life of children with mild to moderate chronic kidney disease. Pediatrics 125 (2010), e349–57.
35. Haavisto, A., Korkman, M., Holmberg, C., Jalanko, H., Qvist, E., Neuropsychological profile of children with kidney transplants. Nephrol Dial Transplant 27 (2012), 2594–2601.
36. Hooper, S.R., Gerson, A.C., Johnson, R.J., Mendley, S.R., Shinnar, S., Lande, M.B., et al. Neurocognitive, social-behavioral, and adaptive functioning in preschool children with mild to moderate kidney disease. J Dev Behav Pediatr 37 (2016), 231–238.
37. Lande, M.B., Gerson, A.C., Hooper, S.R., Cox, C., Matheson, M., Mendley, S.R., et al. Casual blood pressure and neurocognitive function in children with chronic kidney disease: a report of the children with chronic kidney disease cohort study. Clin J Am Soc Nephrol 6 (2011), 1831–1837.
38. Lopes, M., Ferraro, A., Koch, V.H., Health-related quality of life of children and adolescents with CKD stages 4-5 and their caregivers. Pediatr Nephrol 29 (2014), 1239–1247.
39. Moreira, J.M., Bouissou Morais Soares, C.M., Teixeira, A.L., Simões, E., Silva, A.C., Kummer, A.M., Anxiety, depression, resilience and quality of life in children and adolescents with pre-dialysis chronic kidney disease. Pediatr Nephrol 30 (2015), 2153–2162.
40. Roumelioti, M.E., Wentz, A., Schneider, M.F., Gerson, A.C., Hooper, S., Benfield, M., et al. Sleep and fatigue symptoms in children and adolescents with CKD: a cross-sectional analysis from the chronic kidney disease in children (CKiD) study. Am J Kidney Dis 55 (2010), 269–280.
41. Tong, A., Lowe, A., Sainsbury, P., Craig, J.C., Experiences of parents who have children with chronic kidney disease: a systematic review of qualitative studies. Pediatrics 121 (2008), 349–360.
42. Tong, A., Tjaden, L., Howard, K., Wong, G., Morton, R., Craig, J.C., Quality of life of adolescent kidney transplant recipients. J Pediatr 159 (2011), 670–675 e2.
43. Tong, A., Wong, G., McTaggart, S., Henning, P., Mackie, F., Carroll, R.P., et al. Quality of life of young adults and adolescents with chronic kidney disease. J Pediatr 163 (2013), 1179–1185 e5.
44. Thys, K., Schwering, K.L., Siebelink, M., Dobbels, F., Borry, P., Schotsmans, P., et al. Psychosocial impact of pediatric living-donor kidney and liver transplantation on recipients, donors, and the family: a systematic review. Transpl Int 28 (2015), 270–280.
45. Williams, K., Thomson, D., Seto, I., Contopoulos-Ioannidis, D.G., Ioannidis, J.P., Curtis, S., et al. Standard 6: age groups for pediatric trials. Pediatrics 129:suppl 3 (2012), S153–60.
46. Zarin, D.A., Tse, T., Williams, R.J., Califf, R.M., Ide, N.C., The ClinicalTrials.gov results database—update and key issues. N Engl J Med 364 (2011), 852–860.
47. Boers, M., Kirwan, J.R., Wells, G., Beaton, D., Gossec, L., d'Agostino, M.A., et al. Developing core outcome measurement sets for clinical trials: OMERACT filter 2.0. J Clin Epidemiol 67 (2014), 745–753.
48. Black, N., Patient reported outcome measures could help transform healthcare. BMJ, 346, 2013, f167.
49. Fleming, T.R., DeMets, D.L., Surrogate end points in clinical trials: are we being misled?. Ann Intern Med 125 (1996), 605–613.
50. Chertow, G.M., Block, G.A., Correa-Rotter, R., Drueke, T.B., Floege, J., Goodman, W.G., et al. Effect of cinacalcet on cardiovascular disease in patients undergoing dialysis. N Engl J Med 367 (2012), 2482–2494.
51. Halimi, J.M., Sautenet, B., Gatault, P., Roland, M., Giraudeau, B., Renal endpoints in renal and cardiovascular randomized clinical trials: time for a consensus?. Fundam Clin Pharmacol 26 (2012), 771–782.
52. Palmer, S.C., Hayen, A., Macaskill, P., Pellegrini, F., Craig, J.C., Elder, G.J., et al. Serum levels of phosphorus, parathyroid hormone, and calcium and risks of death and cardiovascular disease in individuals with chronic kidney disease: a systematic review and meta-analysis. JAMA 305 (2011), 1119–1127.
53. Palmer, S.C., Teixeira-Pinto, A., Saglimbene, V., Craig, J.C., Macaskill, P., Tonelli, M., et al. Association of drug effects on serum parathyroid hormone, phosphorus, and calcium levels with mortality in CKD: a meta-analysis. Am J Kidney Dis 66 (2015), 962–971.
54. Perkovic, V., Neal, B., Trials in kidney disease—time to EVOLVE. N Engl J Med 367 (2012), 2541–2542.
55. Urquhart-Secord, R., Craig, J.C., Hemmelgarn, B., Tam-Tham, H., Manns, B., Howell, M., et al. Patient and caregiver priorities for outcomes in hemodialysis: an International Nominal Group Technique Study. Am J Kidney Dis 68 (2016), 444–454.
56. Sinha, I.P., Gallagher, R., Williamson, P.R., Smyth, R.L., Development of a core outcome set for clinical trials in childhood asthma: a survey of clinicians, parents, and young people. Trials, 13, 2012, 103.
57. Tong, A., Henning, P., Wong, G., McTaggart, S., Mackie, F., Carroll, R.P., et al. Experiences and perspectives of adolescents and young adults with advanced CKD. Am J Kidney Dis 61 (2013), 375–384.
58. Nicholas, D.B., Picone, G., Selkirk, E.K., The lived experiences of children and adolescents with end-stage renal disease. Qual Health Res 21 (2011), 162–173.
59. Sattoe, J.N., Hilberink, S.R., Peeters, M.A., van Staa, A., ‘Skills for growing up’: supporting autonomy in young people with kidney disease. J Ren Care 40 (2014), 131–139.
60. Tjaden, L., Tong, A., Henning, P., Groothoff, J., Craig, J.C., Children's experiences of dialysis: a systematic review of qualitative studies. Arch Dis Child 97 (2012), 395–402.
61. Harman, N.L., Bruce, I.A., Kirkham, J.J., Tierney, S., Callery, P., O'Brien, K., et al. The importance of integration of stakeholder views in core outcome set development: otitis media with effusion in children with cleft palate. PLoS ONE, 10, 2015 e0129514.
62. Tong, A., Morton, R., Howard, K., Craig, J.C., Adolescent experiences following organ transplantation: a systematic review of qualitative studies. J Pediatr 155 (2009), 542–549 e5.
63. Karamanidou, C., Weinman, J., Horne, R., A qualitative study of treatment burden among haemodialysis recipients. J Health Psychol 19 (2014), 556–569.
64. McConachie, H., Parr, J.R., Glod, M., Hanratty, J., Livingstone, N., Oono, I.P., et al. Systematic review of tools to measure outcomes for young children with autism spectrum disorder. Health Technol Assess, 2015 19.41.
65. Hall, N.J., Kapadia, M.Z., Eaton, S., Chan, W.W.Y., Nickel, C., Pierro, A., et al. Outcome reporting in randomised controlled trials and meta-analyses of appendicitis treatments in children: a systematic review. Trials 16 (2015), 1–14.
66. Morris, C., Janssens, A., Shilling, V., Allard, A., Fellowes, A., Tomlinson, R., et al. Meaningful health outcomes for paediatric neurodisability: stakeholder prioritisation and appropriateness of patient reported outcome measures. Health Qual Life Outcomes 13 (2015), 1–9.
67. Vargus-Adams, J.N., Martin, L.K., Measuring what matters in cerebral palsy: a breadth of important domains and outcome measures. Arch Phys Med Rehabil 90 (2009), 2089–2095.
68. Harman, N.L., Bruce, I.A., Callery, P., Tierney, S., Sharif, M.O., O'Brien, K., et al. MOMENT—Management of Otitis Media with Effusion in Cleft Palate: protocol for a systematic review of the literature and identification of a core outcome set using a Delphi survey. Trials, 14, 2013, 70.
69. Gargon, E., Williamson, P.R., Altman, D.G., Blazeby, J.M., Clarke, M., The COMET initiative database: progress and activities update (2014). Trials 16 (2015), 1–5.
70. Tong, A., Manns, B., Hemmelgarn, B., Wheeler, D.C., Tugwell, P., Winkelmayer, W.C., et al. Standardised outcomes in nephrology—Haemodialysis (SONG-HD): study protocol for establishing a core outcome set in haemodialysis. Trials 16 (2015), 1–9.
71. Tong, A., Samuel, S., Zappitelli, M., Dart, A., Furth, S., Eddy, A., et al. Standardised Outcomes in Nephrology-Children and Adolescents (SONG-Kids): a protocol for establishing a core outcome set for children with chronic kidney disease. Trials, 17, 2016, 401.